Intelligent Bio Solutions Inc Revenue Growth Rates (INBS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Intelligent Bio Solutions Inc   (NASDAQ: INBS)
 

INBS's Revenue Growth by Quarter and Year

Intelligent Bio Solutions Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INBS Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June 1.15
3rd Quarter March 1.06
2nd Quarter December 0.90
1st Quarter September 1.11
FY 4.22

INBSs Annual Revenue
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2026 $ 4.22 millions
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2025 $ 2.25 millions
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2024 $ 2.43 millions
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2023 $ 1.26 millions
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2022 $ 0.44 millions




INBS Revenue fourth quarter 2025 Y/Y Growth Comment
Intelligent Bio Solutions Inc reported Revenue improvement of 36.41% year on year in the fourth quarter 2025, to $ 1.15 millions, this is lower than Intelligent Bio Solutions Inc 's recent average Revenue rise of 53.9%.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 131 other companies have achieved higher Revenue growth. While Intelligent Bio Solutions Inc ' s Revenue rise of 36.41% ranks overall at the positon no. 2479 in the fourth quarter 2025.


INBS Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter June 36.41 % 15.07 % 461.54 % 85.71 %
3rd Quarter March 45.21 % -10.98 % 78.26 % 142.11 %
2nd Quarter December 47.54 % -19.74 % 111.11 % 100 %
1st Quarter September 27.59 % 8.75 % 158.06 % -
FY   38.22 % -1.93 % 146.83 % -

Financial Statements
Intelligent Bio Solutions Inc 's fourth quarter 2025 Revenue $ 1.15 millions INBS's Income Statement
Intelligent Bio Solutions Inc 's fourth quarter 2024 Revenue $ 0.84 millions Quarterly INBS's Income Statement


INBS Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter June 8.09 % 15.07 % -10.98 % -71.74 %
3rd Quarter March 17.78 % 19.67 % 7.89 % 27.78 %
2nd Quarter December -18.92 % -29.89 % -5 % 16.13 %
1st Quarter September 32.14 % 19.18 % 515.38 % 342.86 %
FY (Year on Year)   38.22 % -1.93 % 146.83 % -


Back to INBS Growth rate Comparisons >> Back to INBS Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #132
Healthcare Sector #360
Overall #2479

Revenue Y/Y Growth Statistics
High Average Low
132.7 % 53.9 % -10.55 %
(Sep 30 2023)   (Mar 31 2025)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #132
Healthcare Sector #360
Overall #2479
Revenue Y/Y Growth Statistics
High Average Low
132.7 % 53.9 % -10.55 %
(Sep 30 2023)   (Mar 31 2025)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Intelligent Bio Solutions Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2809.63 % 280.38 % -100 %
(Sep 30 2025)  


INBS's IV. Quarter Q/Q Revenue Comment
Intelligent Bio Solutions Inc achieved in the IV. Quarter 2025 below company average Revenue increase of 8.09% quarter on quarter, to $ 1.15 millions.

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Intelligent Bio Solutions Inc 's Revenue growth quarter on quarter, overall rank is 879.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #137
Overall #879
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #137
Overall #879
Revenue Q/Q Growth Statistics
High Average Low
2809.63 % 280.38 % -100 %
(Sep 30 2025)  


INBS's IV. Quarter Q/Q Revenue Comment
Intelligent Bio Solutions Inc achieved in the IV. Quarter 2025 below company average Revenue increase of 8.09% quarter on quarter, to $ 1.15 millions.

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Intelligent Bio Solutions Inc 's Revenue growth quarter on quarter, overall rank is 879.


Intelligent Bio Solutions Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 4.22 $ 3.91 $ 3.58 $ 3.29 $ 3.05
Y / Y Revenue Growth (TTM) 38.09 % 33.26 % 18.14 % 3.26 % -1.9 %
Year on Year Revenue Growth Overall Ranking # 2941 # 2631 # 380 # 163 # 101
Seqeuential Revenue Change (TTM) 7.72 % 9.27 % 8.79 % 7.85 % 3.95 %
Seq. Revenue Growth (TTM) Overall Ranking # 2479 # 2750 # 2528 # 1315 # 2123


Cumulative Revenue growth Comment
Although Intelligent Bio Solutions Inc 's Annual Revenue growth year on year were below company's average 53.9% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 38.09% year on year, from 33.26% in Mar 31 2026.

In the Healthcare sector 405 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2631 to 2941.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 132
Healthcare Sector # 406
Overall # 2941

Revenue TTM Y/Y Growth Statistics
High Average Low
132.7 %
 53.9 %
-10.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 132
Sector # 360
S&P 500 # 2479
Cumulative Revenue growth Comment
Although Intelligent Bio Solutions Inc 's Annual Revenue growth year on year were below company's average 53.9% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 38.09% year on year, from 33.26% in Mar 31 2026.

In the Healthcare sector 405 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2631 to 2941.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 132
Healthcare Sector # 406
Overall # 2941

Revenue TTM Y/Y Growth Statistics
High Average Low
132.7 %
53.9 %
-10.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 132
Sector # 360
S&P 500 # 2479




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
INBS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Anteris Technologies Global Corp 63.27%$ 63.269 millions
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions
Mannkind Corporation42.92%$ 42.922 millions
Butterfly Network Inc 42.47%$ 42.466 millions
Beta Bionics Inc 42.26%$ 42.261 millions
Vyne Therapeutics Inc 40.58%$ 40.580 millions
Qhslab Inc 39.98%$ 39.978 millions
Coherus Oncology inc 39.53%$ 39.526 millions
Neurocrine Biosciences Inc 39.49%$ 39.491 millions
Ss Innovations International Inc39.39%$ 39.393 millions
Assembly Biosciences Inc 38.94%$ 38.936 millions


About Intelligent Bio Solutions Inc Revenue Growth Rates (INBS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Intelligent Bio Solutions Inc (CIK 1725430).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-039136
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Intelligent Bio Solutions Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.